Temporal Exposure Dependence Bias in Vaccine Efficacy Trials
By: Hiroyasu Ando, A. James O'Malley, Akihiro Nishi
Potential Business Impact:
Fixes how we measure if vaccines work.
Using time-to-event methods such as Cox proportional hazards models, it is well established that unmeasured heterogeneity in exposure or infection risk can lead to downward bias in point estimates of the per-contact vaccine efficacy (VE) in infectious disease trials. In this study, we explore an unreported source of bias-arising from temporally correlated exposure status-that is typically unmeasured and overlooked in standard analyses. Although this form of bias can plausibly affect a wide range of VE trials, it has received limited empirical attention. We develop a mathematical framework to characterize the mechanism of this bias and derive a closed-form approximation to quantify its magnitude without requiring direct measurement of exposure. Our findings show that, under realistic parameter settings, the resulting bias can be substantial. These results suggest that temporally correlated exposure should be recognized as a potentially important factor in the design and analysis of infectious disease vaccine trials.
Similar Papers
Debiasing hazard-based, time-varying vaccine effects using vaccine-irrelevant infections: An observational extension of a pivotal Phase 3 COVID-19 vaccine efficacy trial
Methodology
Makes vaccine protection estimates more accurate over time.
Nonparametric bounds for vaccine effects in randomized trials
Methodology
Finds vaccine's true protection, even if people know they got it.
Multiply Robust Estimation of Conditional Survival Probability with Time-Varying Covariates
Methodology
Helps track sickness risk with changing health data.